Velocity Clinical Research Leipzig GmbH

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Atopic dermatitis (eczema)1 trial
• Osteoarthritis1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 41 trial

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Chiesi Farmaceutici S.p.A.1 trial
• Eli Lilly and Company1 trial
• Grünenthal GmbH1 trial
• Mira Zuidgeest1 trial

Running trials

• Recruiting

  Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma

  NCT07301736· Phase 2· Chiesi Farmaceutici S.p.A.· Source

Closed trials

• Completed

  Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)

  NCT05780151· Phase 4· Mira Zuidgeest· Source

• Completed

  Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

  NCT05248386· Phase 3· Grünenthal GmbH· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source